During the past decade, Weifang People's Hospital conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Weifang People's Hospital" #1 sponsor was "BeiGene" with 9 trials, followed by "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 3 trials sponsored, "Shandong Provincial Hospital" with 3 trials sponsored, "Immune Cell, Inc." with 2 trials sponsored and "Janssen Research & Development, LLC" with 2 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Weifang People's Hospital" #1 collaborator was "Weifang People's Hospital" with 3 trials as a collaborator, "Affiliated Hospital of Qinghai University" with 1 trials as a collaborator, "BeiGene, Ltd." with 1 trials as a collaborator, "Beijing 302 Hospital" with 1 trials as a collaborator and "Beijing Friendship Hospital" with 1 trials as a collaborator. Other collaborators include 28 different institutions and companies that were collaborators in the rest 38 trials.

According to Clinical.Site data, the most researched conditions in "Weifang People's Hospital" are "Esophageal Squamous Cell Carcinoma (ESCC)" (3 trials), "Gastric Cancer" (3 trials), "Non-Small Cell Lung Cancer" (3 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials) and "Endometrial Carcinoma" (2 trials). Many other conditions were trialed in "Weifang People's Hospital" in a lesser frequency.

Most popular intervention types in "Weifang People's Hospital" are "Drug" (28 trials), "Biological" (4 trials), "Other" (3 trials), "Diagnostic Test" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Tislelizumab" (8 trials), "Paclitaxel" (5 trials), "Carboplatin" (4 trials), "Cisplatin" (4 trials) and "Pemetrexed" (4 trials). Other intervention names were less common.

The vast majority of trials in "Weifang People's Hospital" are 33 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are 26 active trials in "Weifang People's Hospital". 1 are not yet recruiting, 15 are recruiting, 8 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 3 completed trials in Weifang People's Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Weifang People's Hospital, 6 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".